Cancer Drug based CAR-T Market

A type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patients blood. Then the gene for a special receptor that binds to a certain protein on the patients cancer cells is added to the T cells in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the laboratory and given to the patient by infusion. CAR T-cell therapy is used to treat certain blood cancers, and it is being studied in the treatment of other types of cancer. Also called chimeric antigen receptor T-cell therapy.

Cancer Drug based CAR-T Market contains market size and forecasts of Cancer Drug based on CAR-T in Global, including the following market information:

• Global Cancer Drug based on CAR-T Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Cancer Drug based on CAR-T market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Allogeneic Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cancer Drug based on CAR-T include Fosun Kite Biotechnology, Gilead Sciences, Novartis and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Drug based on CAR-T companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cancer Drug based on CAR-T Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cancer Drug based on CAR-T Market Segment Percentages, by Type, 2021 (%)

• Allogeneic
• Autologous

Global Cancer Drug based on CAR-T Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cancer Drug based on CAR-T Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Pharmacy
• Other

Global Cancer Drug based on CAR-T Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cancer Drug based on CAR-T Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Cancer Drug based on CAR-T revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Cancer Drug based on CAR-T revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Fosun Kite Biotechnology
• Gilead Sciences
• Novartis
• Bristol-Myers Squibb